The findings identify possible targets for future therapies for ribosomopathies, childhood disorders that lead to bone marrow failure (BMF).

CHOP researchers have identified RNA editing events that influence gene expression and phenotype, showing that a single nucleotide change can have large downstream effects.

CHOP is proud to announce the expansion of its Healthy Weight Food Pharmacy to a second location at the Nicholas and Athena Karabots Pediatric Care Center. The aim of the new location is to increase food access to more patient families, while also providing ongoing support to identify and address broader social determinants of health.

After E.K.’s diagnosis with a genetic disorder, his symptoms remained. His family sought help at CHOP, where experts discovered biliary atresia and treated it.

Read a case study about a patient treated by physicians from the Pancreatic Disorders Program.

The Division of Gastroenterology, Hepatology and Nutrition has started and expanded a number of initiatives to attempt to reach children and teens from all races, cultures, backgrounds and socioeconomic statuses.

Psychologists with specialty training in GI disorders help patients and their families better understand how a child’s feelings, fears and emotions can impact their chronic GI condition and vice versa.

Meet Hayat Mousa, MD, the Director of the Suzi and Scott Lustgarten Center for GI Motility. Dr. Mousa recently sat down for an informal Q&A to talk about her vision, what areas she’d like to expand, why she enjoys working with children with motility conditions, and much more.

Learn about CHOP’s full range of motility studies, diagnostic tests and treatments on-site, and our continued quest for new ways to improve children’s lives.

Four-year-old Zach Reesey received a second chance at life through a heart transplant.